Business Description
Founded in 2015 and headquartered in Shenzhen, China, XtalPi Holdings Limited is a technology company that uses artificial intelligence and cloud computing to accelerate drug discovery and chemical research across China, the United States, and other markets. The company provides a range of software and hardware tools that help scientists automate chemical synthesis, identify and optimize drug candidates, and analyze molecular structures more efficiently. XtalPi works with major partners including Pfizer to develop AI-powered research platforms, and with DoveTree to pursue treatments for diseases that have historically been difficult to address. Formerly known as QuantumPharm Inc., the company rebranded under its current name in December 2024.
